Adnexal Diseases: Clinical Trials

198 trials for Adnexal Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

107 completed, 49 unknown, 15 terminated, 13 withdrawn. 198 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4198Completed 107, Unknown 49, Terminated 15, Withdrawn 13, Recruiting 5, Active not recruiting 4, Not yet recruiting 4, Suspended 1

Follow Adnexal Diseases: new trials by email Literature Review of Adnexal Diseases trials Research Report on Adnexal Diseases

Trials (filtered) newest first · largest first

All 198 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CYTALUX Dose Extension Study
CYTALUX (pafolacianine) injection - Cancer in the Lung, Ovarian Cancer
Phase 4Not yet recruitingOn Target Laboratories, LLC1062026-08-152026-08-18
Effects of Metformin and Theory-Based Education in Women With Polycystic Ovary Syndrome
MetFORMIN, Matching Placebo, Theory-Based Behavioral Educational Program - Polycystic Ovary Syndrome (PCOS) Women
Phase 4CompletedJerash Private University9002026-08-012026-09-10
Study Evaluating Safety, Tolerability, and Metabolism of Niraparib
Niraparib - Ovarian Cancer
Phase 4RecruitingUniversity of Miami702026-07-282026-08-05
Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy
Cyclobenzaprine - Minimally Invasive Surgical Procedures, Abnormal Uterine Bleeding, Unspecified
Phase 4Not yet recruitingChristiana Care Health Services362026-07-012026-06-24
A Clincial Study Testing Tirzepatide on Reproductive Function and Metabolic Health in Women With PCOS Who Are Overweight or Obese
Tirzepatide as an adjunct to lifestyle intervention, Placebo as an adjunct to lifestyle intervention - Polycystic Ovary Syndrome (PCOS), Obesity & Overweight
Phase 4RecruitingUniversity of Bonn1982025-12-092026-01-08
Near-Infrared Fluorescence Imaging With Indocyanine Green to Evaluate Bowel Anastomoses in Gynecologic Oncology Surgery
Indocyanine Green, Near-Infrared Fluorescence Imaging System - Gynecologic Cancers, Ovarian Cancer
Phase 4Not yet recruitingIstanbul University502025-09-012025-03-14
Metformin Effects on Metabolic, Vitamin B12, Iron, Erythropoietin, and Hematological Parameters in Women With PCOS
Metformin, Matching Placebo - Polycystic Ovary Syndrome (PCOS) Women
Phase 4CompletedJerash Private University4002025-08-012026-08-31
Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome
Micronized progesterone 200 MG, Micronized Progesterone 100 MG - Turner Syndrome, Primary Ovarian Insufficiency (Poi)
Phase 4RecruitingChildren's Mercy Hospital Kansas City402025-07-312026-08-25
Comparison of Clomiphene Alone Versus Clomiphene Plus Sildenafil for Ovulation in Women With Polycystic Ovary Syndrome
Clomiphene Citrate 100 mg, Sildenafil Citrate 25Mg Tab, Placebo - Polycystic Ovarian Syndrome (PCOS), Polyendocrine Metabolic Ovarian Syndrome (PMOS)
Phase 4CompletedNishtar Medical University982025-07-012026-08-18
Myo-Inositol and D-Chiro-Inositol for Menstrual Irregularities and Hormone Changes in Women With Polycystic Ovarian Syndrome
Myo-Inositol and D-Chiro-Inositol Combination Therapy, placebo (folic acid) - Polycystic Ovary Syndrome (PCOS), Myo-inositol
Phase 4CompletedNishtar Medical University602025-06-012026-07-14
Liraglutide Treatment in Obese Infertile PCOS Women
Liraglutide and metformin, Metformin - PCOS, Obesity
Phase 4RecruitingPeking University Third Hospital8902025-05-222025-05-29
A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer
Niraparib - Ovarian Neoplasms
Phase 4Not yet recruitingGlaxoSmithKline672025-04-222025-03-21
OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults
Olaparib, Lenvatinib, Sunitinib - Renal Cell Carcinoma, Ovarian Carcinoma
Phase 4UnknownUniversity Medical Center Groningen302024-05-012023-11-29
Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome
Canagliflozin 100mg Tab, Metformin Hydrochloride - Polycystic Ovary Syndrome, Non-Alcoholic Fatty Liver Disease
Phase 4UnknownPing Li,MD502024-03-312024-02-13
Sodium-Glucose Co-Transporter-2 Inhibitors as Adjuvant Therapy With Letrozole in Induction of Ovulation in Women With Polycystic Ovarian Syndrome
Metformin 1000 mg Oral Tablet, Dapagliflozin 10 MG Oral Tablet [Farxiga], Combined Dapagliflozin-Metformin 5/1000mg - Induction of Ovulation, PCO - Polycystic Ovaries
Phase 4CompletedBeni-Suef University5002023-10-202026-10-06
First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients
Olaparib, Bevacizumab - Carcinoma, Ovarian Epithelial
Phase 4Active not recruitingMario Negri Institute for Pharmacological Research1902023-09-152026-06-25
Clinical、metabolomics and the Study of Intestinal Flora of Jinfeng Pills in the Treatment of Polycystic Ovary Syndrome
Jinfeng Pill - Polycystic Ovary Syndrome
Phase 4UnknownPeking Union Medical College Hospital1052023-09-012025-02-12
Letrozole Versus Hormonal Preparation in Frozen Cycles of PCOS Patients.
Letrozole 2.5mg - Frozen Embryo Transfer, Polycystic Ovarian Disease
Phase 4WithdrawnDubai Fertility Center2023-08-012024-02-20
Relationship Between Metformin Treatment, Anemia, and Erythropoietin Levels in Women With Polycystic Ovary Syndrome in Jordan
Metformin - Polycystic Ovary Syndrome (PCOS) Women, Insulin Resistance Syndrome
Phase 4CompletedJerash Private University252023-06-012026-08-12
Metabolic Responses of Metformin and Genetic Polymorphisms of SLC22A1 Gene in PCOS
Metformin Hydrochloride - Polycystic Ovary Syndrome, Metformin
Phase 4Active not recruitingBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh1502023-05-272026-10-07

Showing 20 of 198. Sign in to see all of them.

Narrower conditions

Polycystic Ovary Syndrome (120)  ·  Infertility (37)  ·  Ovarian Neoplasms (31)  ·  Anovulation (18)  ·  Ovarian Hyperstimulation Syndrome (15)  ·  Obesity (13)  ·  Insulin Resistance (12)  ·  Primary Ovarian Insufficiency (10)  ·  Breast Neoplasms (8)  ·  Hyperandrogenism (7)  ·  Ovarian Cysts (6)  ·  Endometritis (5)  ·  Pelvic Inflammatory Disease (5)  ·  Carcinoma, Ovarian Epithelial (4)  ·  Endometrial Neoplasms (4)

Broader conditions

Female Urogenital Diseases (198)  ·  Female Urogenital Diseases and Pregnancy Complications (198)  ·  Genital Diseases (198)  ·  Genital Diseases, Female (198)  ·  Urogenital Diseases (198)  ·  Endocrine System Diseases (188)  ·  Gonadal Disorders (188)  ·  Ovarian Diseases (188)  ·  Neoplasms (160)  ·  Cysts (126)  ·  Ovarian Cysts (120)  ·  Endocrine Gland Neoplasms (35)  ·  Genital Neoplasms, Female (35)  ·  Neoplasms by Site (35)

Interventions

Metformin (46)  ·  Clomiphene (20)  ·  Letrozole (10)  ·  Estradiol (9)  ·  Chorionic Gonadotropin (7)  ·  Folic Acid (7)  ·  Menotropins (6)  ·  Progesterone (6)  ·  Triptorelin Pamoate (6)  ·  Leuprolide (5)  ·  cetrorelix (5)  ·  Ethinyl Estradiol (4)  ·  Gonadotropins (4)  ·  Inositol (4)  ·  Liraglutide (4)

Sponsors

University Magna Graecia (15)  ·  Odense University Hospital (5)  ·  University Medical Centre Ljubljana (4)  ·  Assiut University (3)  ·  First Affiliated Hospital, Sun Yat-Sen University (3)  ·  Jerash Private University (3)  ·  Mohamed Sayed Abdelhafez (3)  ·  Shanghai 10th People's Hospital (3)  ·  AGUNCO Obstetrics and Gynecology Centre (2)  ·  Assaf-Harofeh Medical Center (2)  ·  Bing He (2)  ·  Cairo University (2)  ·  China Academy of Chinese Medical Sciences (2)  ·  Damascus University (2)  ·  Eugonia (2)

Countries

United States (33)  ·  China (24)  ·  Italy (23)  ·  Egypt (15)  ·  Denmark (11)  ·  Spain (5)  ·  Canada (4)  ·  France (4)  ·  United Kingdom (4)  ·  Austria (3)  ·  Greece (3)  ·  India (3)  ·  Iran (3)  ·  Israel (3)  ·  Jordan (3)

Top investigators

Stefano Palomba, MD (14)  ·  Francesco Orio, MD (8)  ·  Achille Tolino, MD (7)  ·  Fulvio Zullo, MD (3)  ·  Mohamed S Abdelhafez, Dr (3)  ·  Shen Qu, Dr (3)  ·  Abdul Hakim Nattouf, MD, PhD (2)  ·  Ahmed Gibreel, Dr (2)  ·  Ahmed Gibreel, MD (2)  ·  Ahmed Maged, MD (2)  ·  Lawrence Engmann, MD (2)  ·  Marwan Alhalabi, MD, PhD (2)  ·  Rachel Mejia, DO (2)  ·  Sally Kadoura, B Pharm, MD (2)  ·  Tryfon Lainas, PhD (2)

Results publications

PMID 23857221, PMID 27529295, PMID 28143456, PMID 33347618, PMID 34732660, PMID 11163814, PMID 11726570, PMID 12046553, PMID 14688154, PMID 17536071, PMID 17766923, PMID 17854523, PMID 18158291, PMID 18165618, PMID 18172212, PMID 18375410, PMID 18403419, PMID 18440534, PMID 18544618, PMID 18647805, PMID 18997670, PMID 19383827, PMID 19933994, PMID 20008886, PMID 2005218, PMID 20118030, PMID 20148739, PMID 20189560, PMID 20215625, PMID 20435692, PMID 20471009, PMID 20660041, PMID 20716255, PMID 20730705, PMID 20858697, PMID 21123449, PMID 21209881, PMID 21325466, PMID 21601197, PMID 21606131, PMID 21733508, PMID 21880799, PMID 21982727, PMID 22341881, PMID 22343553, PMID 22500852, PMID 22579050, PMID 22777527, PMID 22999793, PMID 23211475

NIH funding

2018 (2), K12HD001259 (1), K23HL119602 (1), K24HD001357 (1), P50HD012303 (1), R01DA013131 (1), R01HL075079 (1)